Moxifloxacin 0.5%, Bromfenac 0.09%, Prednisolone Acetate 1%
Generic Name: moxifloxacin 0.5%, bromfenac 0.09%, prednisolone acetate 1%
Brand Names:
Strenza Plus
Rx Only NDC 73614-732-03 For Use in Eyes Only STRENZA Plus ™ Each Pack Contains: Moxifloxacin Ophthalmic Solution, USP 0.5% - One 3 ml Bottle Bromfenac Ophthalmic Solution 0.09% - One 1.7 ml Bottle Prednisolone Acetate Ophthalmic Suspension, USP 1% - One 5 ml Bottle Brisk Pharmaceuticals
Overview
Rx Only NDC 73614-732-03 For Use in Eyes Only STRENZA Plus ™ Each Pack Contains: Moxifloxacin Ophthalmic Solution, USP 0.5% - One 3 ml Bottle Bromfenac Ophthalmic Solution 0.09% - One 1.7 ml Bottle Prednisolone Acetate Ophthalmic Suspension, USP 1% - One 5 ml Bottle Brisk Pharmaceuticals
Related Medications
Bufo Rana, Buxus Sempervirens, Juglans Regia, Nitricum Acidum, Oleander, Stannum Metallicum, Sulphur, Taxus Baccata, Thuja Occidentalis, Vanadium Metallicum
bufo rana, buxus sempervirens, juglans regia, nitricum acidum, oleander, stannum metallicum, sulphur, taxus baccata, thuja occidentalis, vanadium metallicum
Non-Standardized Food Allergenic Extract [EPC]
Uses For the temporary relief of symptoms associated with skin warts.
Nafamostat Mesylate Jp
nafamostat mesylate jp
Dosage form: POWDER. Active ingredients: NAFAMOSTAT MESYLATE (1 kg/kg). Category: BULK INGREDIENT.
Eladocagene Exuparvovec-tneq
eladocagene exuparvovec-tneq
11 DESCRIPTION KEBILIDI (eladocagene exuparvovec-tneq) is a gene therapy product that expresses the human aromatic L-amino acid decarboxylase enzyme (hAADC). It is a recombinant adeno-associated virus serotype 2 (rAAV2) based vector containing the complementary DNA of the human DDC gene under the control of the cytomegalovirus immediate-early promoter. Eladocagene exuparvovec-tneq is produced in human embryonic kidney cells by recombinant DNA technology.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.